Life Sciences: Blogs

No Place to Hide: Shedding Light on Pharma Price Transparency

The rising tide of pharmaceutical price transparency laws and what they mean for the future of drug pricing For pharma manufacturers, price transparency is no longer just a policy issue—it’s a business imperative.

May 9, 2025

The Undertow Threatening Your Pricing Strategy: Parallel Trade

What if your carefully curated pricing strategy, tailored to regional economic conditions and market demands, was washed away by someone else profiting from the difference?

March 7, 2025

Anchors Up! Are You Ready To Set Sail On The Value-Based Voyage?

The medical device industry is transforming significantly from simple, disposable products like syringes and wheelchairs to complex, multifunctional devices capable of diagnostics, remote monitoring and direct patient interaction.

November 19, 2024

GtN visibility in life sciences feature image

Clear Skies Ahead: Breaking Through The Gross-to-Net Fog

In the complex life sciences landscape of financial and commercial operations, gaining clear visibility into your Gross-to-Net (GtN) process is no longer a “nice-to-have” – it's fundamental to making strategic business decisions.

November 11, 2024

Redefining Digital Transformation: A Vital Strategy For Life Sciences

Digital transformation is now a pivotal lever for growth and innovation in the life sciences industry. Various influences – from pricing pressures to more stringent compliance and operational siloes are changing the landscape, especially for pharma and MedTech.

June 21, 2024

340B Compliance: Making It Pay

Do you know a surefire way to eat away at your razor-thin margins? Manual processes involving government compliance.

May 6, 2024

On The Edge Of A New Frontier

You don’t need to look far to see that medical device innovations are the “new frontier” of the Life Sciences industry.

March 13, 2024

medical device pricing strategies featured image

The Margin Squeeze Trap: Growing Tighter For The Medical Device Industry

Implementing the right pricing strategies for medical devices is crucial for achieving optimal profit margins.

October 16, 2023

Doctor Byte: What’s Next In Digital Health And Digital Therapeutics (DTx)

What are digital health and digital therapeutics, and what role do medical device and pharma companies play? 7:00 in the morning my watch reminds me that yesterday I reache...

June 2, 2023

Commercial Policies Framework feature image

Your Next Profit Booster: A Healthy Dose Of Commercial Policies Framework

The importance of commercial policies framework in Life Sciences Did you know you can boost margins and profits beyond controlling pricing and contracts in sales? A healthy dose of a...

April 10, 2023

Are You Mining Your Data, Hoping For Gold, And Getting Dirt?

Data is the new currency in Life Sciences and analytics is the pot of gold What if what you think you know just ain’t so? Mark Twain is credited with saying: “It ain’t what...

January 3, 2023

Riding The CMO/CDMO Collaboration Wave

CMO and CDMO partnerships are gaining momentum The Life Sciences industry was always viewed as a stable industry until the 2007-2009 economic downturn brought about interes...

June 7, 2022

Why is it important as a company to understand your net price?

Success in Gross-to-Net Management Affects Your Entire Business

Cookie Cutter Tools Are For Baking, Not Financials Achieving a true net price of a product is a challenge for Life Sciences manufacturers. Gross-to-Net (GTN) is not a simpl...

February 6, 2022

determine reimbursements with scenario planning

Think Again. And Again.

December 20, 2021

3 ways to manage return and recall pricing

To Return, Or Not To Return, That Is The Question

Return management in pharma: finding the right price Returns on drugs and medical devices are inevitable. Pricing a returned product is not an easy task for pharma and medi...

November 15, 2021

Pandemic Causes 3D Printing Epidemic in the Medical Industry

How a burgeoning technology is changing the future of healthcare “What began during the pandemic in response to a critical need has expanded to change the way healthcare is...

May 11, 2021

Life Sciences Data, Is it Helping or Hurting?

You’ve Got Data. Is It Helping Or Hurting?

Raise the bar—and the bottom line Opportunity could be staring you in the face, but you might not recognize it. As a Life Sciences company, you have so much data. Are you m...

April 21, 2021

Chess anyone? Life Sciences Industry Trends in 2021 and Beyond

Now that the new year is upon us, I’m looking ahead and trying to imagine what new opportunities and challenges we’ll face in Life Sciences. At times like this, when there ...

January 21, 2021

Status Quo? No Go for The Life Sciences Supply Chain

It seems like such a logical approach—in a global economy, concentrate the production of low-cost items in low-cost countries, simplify supply chains, and employ lean manuf...

December 14, 2020

What’s a life-saving drug worth? It depends…

Drug development is a high-risk, high-reward business. The risk? According to Medicinenet.com, only 5 in 5,000 drugs that enter preclinical testing advance to human trial...

October 21, 2020

The race to a vaccine – unintended consequences?

A gold rush is on to find a vaccine for COVID-19. According to the World Health Association (WHO) in early May, there are more than 100 projects around the world centered o...

June 4, 2020

Reducing cost and time to market in drug development: The importance of royalties for Pharma and Biopharmaceuticals

Within the last few decades, the cost and time to market for new drug development has soared. Nowadays, it takes an average of 15 years from first molecule investigations u...

April 3, 2020

The Power of Outcome-Based Pricing

In February of 2019, CEOs and senior executives from seven major pharmaceutical companies met with the Senate Finance Committee about drug pricing. During that meeting, Ast...

December 11, 2019